Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study.
Scand J Infect Dis
; 46(12): 838-45, 2014 Dec.
Article
in En
| MEDLINE
| ID: mdl-25229167
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oligopeptides
/
Pyridines
/
Pyrrolidinones
/
HIV Infections
/
HIV-1
/
HIV Protease Inhibitors
/
Ritonavir
/
Anti-HIV Agents
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Scand J Infect Dis
Year:
2014
Document type:
Article
Affiliation country:
Francia
Country of publication:
Reino Unido